A letter in The Guardian from campaigners and academics warns that public discussion of human gene editing is skewed toward eliminating hereditary conditions, even though polling shows public support for treating life-threatening disorders—not conditions like deafness. The letter cites the FDA's April 2026 approval of gene therapy for deafness as evidence that policy is moving faster than democratic debate can keep pace.
Who gets framed as a problem to solve matters. If media coverage treats deafness only as a defect and not as identity, culture, and community, the public absorbs a narrow script just as regulators, clinicians, and parents make permanent decisions. Deaf people excluded from the conversation means the terms are set without them.
Whether outlets and policymakers widen the conversation before germline editing gets normalized by momentum alone will matter. The test: do Deaf voices get invited into the policy room, or only quoted after approvals are done?
This is a classic media failure. Reporters love a breakthrough story—heroes, lab coats, clean arc toward progress. But once you frame a human trait as a target for correction, you're not covering science neutrally. You're setting the moral default. If Deaf voices show up only as reaction quotes after the approvals land, the debate is already over. The story isn't whether gene therapy works. It's who gets to decide what counts as broken.
Filed to the Media desk · Jul 15